Cargando…
Impact of comprehensive family history and genetic analysis in the multidisciplinary pancreatic tumor clinic setting
BACKGROUND: Genetic testing is recommended for all pancreatic ductal adenocarcinoma (PDAC) patients. Prior research demonstrates that multidisciplinary pancreatic cancer clinics (MDPCs) improve treatment‐ and survival‐related outcomes for PDAC patients. However, limited information exists regarding...
Autores principales: | Everett, Jessica N., Dettwyler, Shenin A., Jing, Xiaohong, Stender, Cody, Schmitter, Madeleine, Baptiste, Ariele, Chun, Jennifer, Kawaler, Emily A., Khanna, Lauren G., Gross, Seth A., Gonda, Tamas A., Beri, Nina, Oberstein, Paul E., Simeone, Diane M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939217/ https://www.ncbi.nlm.nih.gov/pubmed/35906821 http://dx.doi.org/10.1002/cam4.5059 |
Ejemplares similares
-
Outcomes of Retesting in Patients with Previously Uninformative Cancer Genetics Evaluations
por: Dettwyler, Shenin A., et al.
Publicado: (2022) -
Single-cell RNA sequencing reveals the effects of chemotherapy on human pancreatic adenocarcinoma and its tumor microenvironment
por: Werba, Gregor, et al.
Publicado: (2023) -
Author Correction: Single-cell RNA sequencing reveals the effects of chemotherapy on human pancreatic adenocarcinoma and its tumor microenvironment
por: Werba, Gregor, et al.
Publicado: (2023) -
Tumor infiltrating T cell states and checkpoint inhibitor expression in hepatic and pancreatic malignancies
por: Wan, Shanshan, et al.
Publicado: (2023) -
Corrigendum: Tumor infiltrating T cell states and checkpoint inhibitor expression in hepatic and pancreatic malignancies
por: Wan, Shanshan, et al.
Publicado: (2023)